Patents by Inventor Scott Soderling

Scott Soderling has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210047643
    Abstract: Disclosed herein are the genetic constructs for a Homology-Independent Universal Genome Editing (HiUGE) system and methods of using said HiUGE system for genome editing. The invention relates to compositions comprising gRNA polynucleotides, insert polynucleotides, and a CRISPR-based nuclease or polynucleotide encoding a CRISPR-based nuclease.
    Type: Application
    Filed: February 15, 2019
    Publication date: February 18, 2021
    Inventors: Yudong Gao, Scott Soderling
  • Publication number: 20070116705
    Abstract: The present invention provides isolated full-length nucleic acid molecules encoding the novel PDE protein of the invention, and methods for uses thereof. The nucleic acid molecules of the invention also include peptide nucleic acids (PNA), and antisense molecules that react with the nucleic acid molecules of the invention. The invention also relates to agonists, antibodies, antagonists or inhibitors of the activity of novel PDE proteins. These compositions are useful for the diagnosis, prevention or treatment of conditions associated with the presence or the deficiency of novel PDE proteins.
    Type: Application
    Filed: June 1, 2006
    Publication date: May 24, 2007
    Applicant: University of Washington
    Inventors: Joseph Beavo, Thomas Seebeck, Scott Soderling, Ana Rascon, Roya Zoraghi, Stefan Kunz, Kewei Gong, Natalie Glavas
  • Publication number: 20050058998
    Abstract: The present invention provides isolated full-length nucleic acid molecules encoding the novel PDE protein of the invention, and methods for uses thereof. The nucleic acid molecules of the invention also include peptide nucleic acids (PNA), and antisense molecules that react with the nucleic acid molecules of the invention. The invention also relates to agonists, antibodies, antagonists or inhibitors of the activity of novel PDE proteins. These compositions are useful for the diagnosis, prevention or treatment of conditions associated with the presence or the deficiency of novel PDE proteins.
    Type: Application
    Filed: September 12, 2001
    Publication date: March 17, 2005
    Inventors: Joseph Beavo, Thomas Seebeck, Scott Soderling, Ana Rascon, Roya Zoraghi, Stefan Kunz, Kewen Gong, Natalie Glavas